ClinVar Miner

Submissions for variant NM_000060.2(BTD):c.[511G>A;1330G>C]

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000021936 SCV000711610 pathogenic Biotinidase deficiency 2017-01-31 criteria provided, single submitter clinical testing The p.[Ala171Thr;Asp444His] (NM_000060.2 c.[511G>A;1330G>C]) allele in BTD has p reviously been reported in several compound heterozygous individuals with biotin idase deficiency (Norrgard 1998 and Borsatto 2014). While the frequency of the c ombined allele in the general population is not documented, the p.Ala171Thr vari ant has only been reported in individuals who carried the more common partial de ficiency p.Asp444His variant, suggesting that these two variants may always occu r on the same chromosome and the frequency of the combined allele may be the sam e as the reported frequency of the p.Ala171Thr variant alone in the population (47/120,592 of chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs13073139)); however, this cannot be conclusively d etermined. In summary, the p.[Ala171Thr;Asp444His] allele meets our criteria to be classified as pathogenic for biotinidase deficiency in an autosomal recessive manner primarily based upon its occurrence in trans with other pathogenic varia nts in affected individuals. Although the p.Asp444His variant on its own has par tial activity, the p.[Ala171Thr;Asp444His] combined allele is thought to represe nt a more severe effect.
Johns Hopkins Genomics, Johns Hopkins University RCV000021936 SCV001762382 pathogenic Biotinidase deficiency 2021-06-21 criteria provided, single submitter clinical testing c.[451G>A;1270G>C] is a complex allele containing two BTD variants (rs13073139; rs13078881) that are located on the same chromosome (in cis). Each variant has an entry in ClinVar. c.451G>A is rare (<0.1%) in a large population dataset (gnomAD: 87/282712 total alleles, 0.03%, no homozygotes), while c.1207G>C is polymorphic (3.19%) in most ancestral populations. This allele is a common cause of profound bioitinidase deficiency (less than 10% mean normal activity in serum) when it occurs in a compound heterozygous state (in trans) with another pathogenic BTD variant. It accounts for approximately 17% of BTD variants in children with profound biotinidase deficiency identified by newborn screening in the United States. This allele was detected in the patient’s father and was absent in the patient’s mother confirming that these two variants are on the same chromosome. We consider this complex allele, which combines c.451G>A and c.1207G>C, to be pathogenic.
OMIM RCV000021936 SCV000022135 pathogenic Biotinidase deficiency 2011-01-12 no assertion criteria provided literature only
Research and Development, ARUP Laboratories RCV000021936 SCV000042605 pathogenic Biotinidase deficiency 2012-12-04 no assertion criteria provided clinical testing Converted during submission to Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.